Akcea Therapeutics Overview

  • Founded
  • 2015

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 294

Employees
  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Akcea Therapeutics General Information

Description

Akcea Therapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. It is advancing a mature pipeline of novel drugs with the potential to treat multiple diseases. The company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. Its most advanced drug, volanesorsen, has completed a Phase 3 clinical program for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL.

Contact Information

Website
www.akceatx.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 22 Boston Wharf Road
  • 9th Floor
  • Boston, MA 02210
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akcea Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Akcea Therapeutics‘s full profile, request access.

Request a free trial

Akcea Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Akcea Therapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing drugs t
Biotechnology
Boston, MA
294 As of 2019
00000
0.000 0000-00-00
000000&0 00000

000 00

a. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
0000 000000000
South San Francisco, CA
000 As of 0000
00000
000000000 00000

000000

at. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla par
0000000000000
Newark, CA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akcea Therapeutics Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NGM Biopharmaceuticals Formerly VC-backed South San Francisco, CA 000 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Newark, CA 00 00000 00000000 00000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000000 00.000
000000000(00000000 Formerly VC-backed New York, NY 000 00000 000000 - 000 00000
0000000 0000000000 Formerly VC-backed Cambridge, MA 0000 00.000 0000 00.000
You’re viewing 5 of 17 competitors. Get the full list »

Akcea Therapeutics Executive Team (17)

Name Title Board Seat Contact Info
Michael Price Executive Vice President & Chief Financial Officer
You’re viewing 1 of 17 executive team members. Get the full list »

Akcea Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akcea Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Akcea Therapeutics‘s full profile, request access.

Request a free trial